Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Amritava Das

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Therapeutics and Clinical Risk Management|September 21, 2018
The potential of CAR T therapy for relapsed or refractory pediatric and young adult B-cell ALLMatthew H Forsberg, Amritava Das, Krishanu Saha, et al.
Biotechnology and Bioengineering|June 7, 2013
Improving efficiency of human pluripotent stem cell differentiation platforms using an integrated experimental and computational approachJoshua A Selekman, Amritava Das, Nicholas J Grundl, et al.
The Journal of Surgical Research|March 31, 2015
Epidermal growth factor mediated healing in stem cell-derived vocal fold mucosaLiliana Palencia, Amritava Das, Sean P Palecek, et al.
Acta Biomaterialia|November 9, 2013
Temporal impact of substrate mechanics on differentiation of human embryonic stem cells to cardiomyocytesLaurie B Hazeltine, Mehmet G Badur, Xiaojun Lian, et al.
Biotechnology Journal|August 26, 2017
Bioengineering Solutions for Manufacturing Challenges in CAR T CellsNicole J Piscopo, Katherine P Mueller, Amritava Das, et al.
Cytotherapy|August 26, 2019
A multiscale simulation framework for the manufacturing facility and supply chain of autologous cell therapiesKan Wang, Yi Liu, Junxuan Li, et al.
Nature Communications|December 9, 2020
Design of efficacious somatic cell genome editing strategies for recessive and polygenic diseasesJared Carlson-Stevermer, Amritava Das, Amr A Abdeen, et al.
Cytotherapy|February 27, 2023
Label-free in vitro assays predict the potency of anti-disialoganglioside chimeric antigen receptor T-cell productsMeghan Logun, Maxwell B Colonna, Katherine P Mueller, et al.
Journal for Immunotherapy of Cancer|November 16, 2022
Production and characterization of virus-free, CRISPR-CAR T cells capable of inducing solid tumor regressionKatherine P Mueller, Nicole J Piscopo, Matthew H Forsberg, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Therapeutics and Clinical Risk Management|September 21, 2018
The potential of CAR T therapy for relapsed or refractory pediatric and young adult B-cell ALLMatthew H Forsberg, Amritava Das, Krishanu Saha, et al.
Biotechnology and Bioengineering|June 7, 2013
Improving efficiency of human pluripotent stem cell differentiation platforms using an integrated experimental and computational approachJoshua A Selekman, Amritava Das, Nicholas J Grundl, et al.
The Journal of Surgical Research|March 31, 2015
Epidermal growth factor mediated healing in stem cell-derived vocal fold mucosaLiliana Palencia, Amritava Das, Sean P Palecek, et al.
Acta Biomaterialia|November 9, 2013
Temporal impact of substrate mechanics on differentiation of human embryonic stem cells to cardiomyocytesLaurie B Hazeltine, Mehmet G Badur, Xiaojun Lian, et al.
Biotechnology Journal|August 26, 2017
Bioengineering Solutions for Manufacturing Challenges in CAR T CellsNicole J Piscopo, Katherine P Mueller, Amritava Das, et al.
Cytotherapy|August 26, 2019
A multiscale simulation framework for the manufacturing facility and supply chain of autologous cell therapiesKan Wang, Yi Liu, Junxuan Li, et al.
Nature Communications|December 9, 2020
Design of efficacious somatic cell genome editing strategies for recessive and polygenic diseasesJared Carlson-Stevermer, Amritava Das, Amr A Abdeen, et al.
Cytotherapy|February 27, 2023
Label-free in vitro assays predict the potency of anti-disialoganglioside chimeric antigen receptor T-cell productsMeghan Logun, Maxwell B Colonna, Katherine P Mueller, et al.
Journal for Immunotherapy of Cancer|November 16, 2022
Production and characterization of virus-free, CRISPR-CAR T cells capable of inducing solid tumor regressionKatherine P Mueller, Nicole J Piscopo, Matthew H Forsberg, et al.
Pageof 1